Creatinine Clearance Calculator

🩺 Creatinine Clearance Calculator

Estimate renal function using the Cockcroft-Gault equation.

.

Creatinine Clearance (Cockcroft-Gault)

mL/min

Please enter all parameters.

(mL/min)
G5
G4
G3a/b
G2
G1
15 30 60 90
Show calculation steps

Recent Updates

  • Drug-dose adjustment is recommended to transition from Cockcroft-Gault toward the race-free 2021 CKD-EPI eGFR (de-indexed to mL/min), per 2024 FDA renal-impairment guidance and a 2025 NKF medication workgroup. Cockcroft-Gault remains in common use and still underlies many drug labels, including DOAC dosing.
  • The KDIGO 2024 CKD guideline reaffirms eGFR (CKD-EPI 2021) rather than creatinine clearance for CKD staging.

Source: St Peter WL, et al. NKF Workgroup recommendations for race-free eGFR-based medication-related decisions (2025). Am J Health-Syst Pharm 2025;82(12):644-659. PMID: 39552516

Key Knowledge Points

  • The Cockcroft-Gault equation provides an estimate of renal function, not a direct measurement.
  • This Creatinine Clearance Calculator is widely used for drug dosage adjustments, as many drug labels (including DOACs) were based on it. Guidelines now recommend transitioning toward race-free eGFR (de-indexed to mL/min) for dosing, but verify against the specific product label.
  • The formula’s accuracy is reduced in patients with extremes of age, weight (e.g., obesity, malnutrition), or muscle mass.
  • For staging Chronic Kidney Disease (CKD), newer formulas like CKD-EPI are generally preferred due to their higher accuracy across different populations.
  • Consider using Ideal or Adjusted Body Weight in obese patients as per institutional or drug-specific guidelines, as using actual body weight may overestimate CrCl.

About This Creatinine Clearance Calculator

The Creatinine Clearance Calculator provides an estimate of a patient’s renal function using the well-established Cockcroft-Gault formula. For decades, this equation has been a cornerstone in clinical practice for assessing kidney function, particularly for adjusting medication dosages. By entering a patient’s age, weight, serum creatinine level, and sex, healthcare professionals can obtain a rapid estimate to guide therapeutic decisions and avoid potential toxicity from drugs that are cleared by the kidneys. While newer formulas are now preferred for staging chronic kidney disease, the Cockcroft-Gault equation remains highly relevant, as many drug-dosing recommendations in pharmaceutical literature are based on Creatinine Clearance (CrCl) values derived from it.

The Formula Explained

The Cockcroft-Gault formula, published in 1976, estimates creatinine clearance from a single serum creatinine measurement. It incorporates key variables that influence creatinine production (age, sex, weight) to provide a more comprehensive picture of renal function than the serum creatinine level alone.

$$ \text{CrCl (mL/min)} = \frac{(140 – \text{Age}) \times \text{Weight (kg)}}{72 \times \text{Serum Creatinine (mg/dL)}} \times [0.85 \text{ if Female}] $$

Clinical Interpretation & Limitations

The calculated CrCl value is sometimes used to categorize the stage of Chronic Kidney Disease (CKD) according to KDIGO guidelines (most recently the KDIGO 2024 update), although the eGFR (CKD-EPI 2021) is the preferred tool for staging. The visual bar provides a quick reference for these stages.

  • Stage G1: ≥90 mL/min (Normal or high kidney function)
  • Stage G2: 60-89 mL/min (Mildly decreased kidney function)
  • Stage G3 (G3a/G3b): 30-59 mL/min (Mild to moderately decreased)
  • Stage G4: 15-29 mL/min (Severely decreased kidney function)
  • Stage G5: <15 mL/min (Kidney failure / End-stage renal disease)

Limitations: It is crucial to be aware of the limitations of this Creatinine Clearance Calculator. Its accuracy can be compromised in several populations, including: the elderly, individuals with very low or high Body Mass Index (BMI), pregnant women, and patients with unstable renal function or significant liver disease.

Frequently Asked Questions (FAQ)

1. Which weight should I use in the calculator: Actual, Ideal, or Adjusted?

This is a critical question. The choice depends on the patient’s BMI and specific drug guidelines. A common approach is:
Normal Weight (BMI < 25): Use Actual Body Weight (ABW).
Overweight/Obese (BMI ≥ 25): Using ABW can significantly overestimate CrCl. Many institutions recommend using Ideal Body Weight (IBW) or an Adjusted Body Weight (AdjBW) to provide a more conservative and safer estimate. Always consult your institution’s protocol or specific drug information.

2. Why is Cockcroft-Gault still used if CKD-EPI is more accurate for staging?

Many drug package inserts and dosing guidelines, especially for older medications, were developed using CrCl values from the Cockcroft-Gault formula. To maintain consistency with this legacy data, clinicians often continue to use this Creatinine Clearance Calculator for dose adjustments. Note that 2024 FDA renal-impairment guidance and a 2025 NKF medication workgroup now recommend transitioning toward the race-free eGFR for dosing — de-indexed from mL/min/1.73m² to mL/min using the patient’s actual body surface area. Cockcroft-Gault nonetheless remains in common use, including for DOAC dose adjustment per current FDA labels, so always verify against the specific product label.

3. What is the difference between CrCl and eGFR?

CrCl (Creatinine Clearance) estimates the rate at which creatinine is cleared from the blood, which approximates the Glomerular Filtration Rate (GFR). eGFR (estimated GFR) is a value from formulas like CKD-EPI, which are statistically derived to estimate GFR and are generally more accurate for staging kidney disease. CrCl tends to slightly overestimate GFR because creatinine is cleared by both glomerular filtration and some tubular secretion.

4. Can this calculator be used for pediatric patients?

No. The Cockcroft-Gault formula is validated for use in adults only. Pediatric renal function estimation requires different formulas, such as the Bedside Schwartz equation, which are specifically designed for children’s physiology.

5. How does unstable renal function affect the calculation?

The Cockcroft-Gault formula assumes a stable serum creatinine level (a “steady state”). In patients with acute kidney injury (AKI), where serum creatinine is rapidly changing day-to-day, the calculation will be inaccurate and should not be relied upon for clinical decisions.

⚠️ Disclaimer:

This tool is for informational and educational purposes only and is not a substitute for professional clinical judgment. All treatment decisions must be made by a qualified healthcare professional considering the individual patient’s full clinical context.